You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

IMPlementing Advances in Cancer Treatment for Patients With HR-Positive, HER2-Negative Early Breast Cancer

Read Overview

Supported by an independent educational grant from Lilly.



CME Activities

CNE Activities

Treating Patients with EBC

Keep in Touch With the HR+/HER2- Early Breast Cancer Treatment Landscape

Resources

Clinical References

Steering Committee

Joyce A. O'Shaughnessy, MD
Joyce A. O'Shaughnessy, MD

Steering Committee Chair

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology
US Oncology
Dallas, Texas, United States

Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD

Steering Committee Chair

Director
Breast Center
Department of Obstetrics and Gynecology
LMU University Hospital
Munich, Germany

Giuseppe Curigliano, MD, PhD
Giuseppe Curigliano, MD, PhD

Professor
University of Milan
Director, Division of Early Drug Development
European Institute of Oncology
Milan, Italy

Erika Hamilton, MD
Erika Hamilton, MD

Director
Breast Cancer Research Program
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee, United States

Stephen R. D. Johnston, MA, FRCP, PhD
Stephen R. D. Johnston, MA, FRCP, PhD

Professor of Breast Cancer Medicine
Head of Medical Oncology
Consultant Medical Oncologist
Head of The Breast Unit
The Royal Marsden NHS Foundation Trust & The Institute of Cancer Research
London, United Kingdom

Sara M. Tolaney, MD, MPH
Sara M. Tolaney, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts, United States